PWE.F PW MEDTECH GROUP DL-0001
- Market cap
- EUR 124M
- P/E
- -
- P/B
- 0.24x
- ROE
- 2.4%
- Dividend yield
- 2.92%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is PWE.F undervalued?
Graham numberThe Graham number of PW MEDTECH GROUP DL-0001 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
PW MEDTECH GROUP DL-0001 fundamental analysis
No fundamental analysis for PW MEDTECH GROUP DL-0001 yet.
PW MEDTECH GROUP DL-0001 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About PW MEDTECH GROUP DL-0001
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, the rest of Asia, and internationally. It operates in three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company offers advanced infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and…
Full company profilePW MEDTECH GROUP DL-0001 financial statements
PW MEDTECH GROUP DL-0001 annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 271M | 537M | 675M | 769M | 824M |
| Gross Profit | 166M | 299M | 381M | 419M | 407M |
| Operating Income | 21.8M | 68.4M | 163M | 139M | 102M |
| EBITDA | - | 237M | 329M | 348M | 306M |
| Net Income | 739M | 106M | 153M | 151M | 94.4M |
| EPS | 0.47 | 0.07 | 0.10 | 0.10 | 0.06 |
| Balance Sheet | |||||
| Total Assets | 3.92B | 4.99B | 5.15B | 5.16B | 5.24B |
| Total Liabilities | 123M | 352M | 327M | 358M | 382M |
| Shareholders' Equity | 3.79B | 3.95B | 4.04B | 3.97B | 3.95B |
| Cash & Short-term Investments | 2.28B | 1.38B | 1.59B | 1.68B | 1.80B |
| Cash Flow | |||||
| Operating Cash Flow | 37.2M | 269M | 211M | 318M | 241M |
| Capital Expenditure | 11.3M | 61.9M | 81.9M | 72.1M | 105M |
| Free Cash Flow | 25.9M | 207M | 129M | 246M | 136M |
| Ratios | |||||
| ROE | 19.5% | 2.7% | 3.8% | 3.8% | 2.4% |
| ROA | 18.9% | 2.1% | 3.0% | 2.9% | 1.8% |
| Net Profit Margin | 272.3% | 19.8% | 22.7% | 19.6% | 11.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
PW MEDTECH GROUP DL-0001 dividends
- Dividend yield
- 2.92%
- Forward dividend
- -
- Payout ratio
- 138.1%
- Ex-dividend date
- Nov 2, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 130M | 0.09 | 138.1% |
| 2024 | CNY 134M | 0.09 | 89.1% |
| 2023 | CNY 71.6M | 0.05 | 46.7% |
| 2022 | - | - | - |
| 2021 | CNY 2.06B | 1.31 | 279.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns PW MEDTECH GROUP DL-0001
- Insiders 74.37%
- Institutions 0.46%
- Public & others 25.17%
- Shares outstanding 1.42B
- Free float 364M
PW MEDTECH GROUP DL-0001 company profile
- Company name
- PW MEDTECH GROUP DL-0001
- Ticker
- PWE.F
- ISIN
- KYG7306W1087
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,433
- Fiscal year end
- December
- Address
- Building 1, Beijing, China, 101204
- Phone
- 86 10 8478 3617
- Website
- pwmedtech.com
About PW MEDTECH GROUP DL-0001
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, the rest of Asia, and internationally. It operates in three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company offers advanced infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical devices; and high-flux hemodialyzers, low-flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. It also provides animal-derived regenerative medical biomaterials and human tissue repair alternative products. The company was formerly known as Pyholding Limited and changed its name to PW Medtech Group Limited in June 2013. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
PW MEDTECH GROUP DL-0001 management
3- Ms. Yue'e ZhangExecutive Chairman & CEO · born 1963
- Ms. Tian TianFinancial Director · born 1982
- Ms. Ka Man So A.C.I.S., A.C.S., FCIS, FCSCompany Secretary · born 1974